Order results by:
| Issue | Title | |
| Vol 2, Issue 1 (2022) | Phase I of Antipsychotics Metabolism and its Pharmacogenetic Testing | Abstract PDF (Eng) similar documents |
| N. A. Shnayder, A. K. Abdyrakhmanova, R. F. Nasyrova | ||
| Vol 2, Issue 1 (2022) | Pharmacogenetic Testing of Cytochrome P450 Metabolizing Enzymes in 28-Year-Old Man with Treatment-Resistant Schizophrenia | Abstract PDF (Eng) similar documents |
| A. K. Abdyrakhmanova, R. F. Nasyrova | ||
| "... metabolism by cytochrome P450 enzymes. Pharmacogenetic testing (PGx) is a method to identify a group ..." | ||
| Vol 2, Issue 1 (2022) | Clinical Case of a 36-Year-Old Man with Treatment-Resistant Paranoid Schizophrenia: Personalized Therapy Selection | Abstract PDF (Eng) similar documents |
| L. P. Linova, A. A. Torgovtsev, O. V. Limankin, R. F. Nasyrova | ||
| "... membrane of APs target neurons in the brain. Pharmacogenetic testing (PGx) is a method to identify a group ..." | ||
| Vol 2, Issue 1 (2022) | Pharmacogenetic Testing of Antipsychotic Transporter Proteins: A Case Report in a 32-Year-Old Woman with Treatment-Resistant Schizophrenia | Abstract PDF (Eng) similar documents |
| S M. Osipova, N. A. Shnayder | ||
| "... . Pharmacogenetic testing (PGx) is a method to identify a group of patients with a high risk of developing AP ..." | ||
| Vol 2, Issue 1 (2022) | PCR-based Approach for Determining the Genetic Risk Factors of Antipsychotic-Induced Metabolic Disorders | Abstract PDF (Eng) similar documents |
| K. O. Mironov, I. I. Gaponova, V. I. Korchagin, A. S. Esman, E. A. Dunaeva, V. A. Zhivotova, V. S. Dobrodeeva, N. A. Shnayder, N. G. Neznanov, R. F. Nasyrova | ||
| Vol 2, Issue 2 (2022) | Clinical Case of a 36-year-old Patient with Paranoid Schizophrenia and Drug-Induced QT Prolongation | Abstract PDF (Eng) similar documents |
| N. M. Zhuravlev, A. P. Otmachov, A. E. Bartasinskaya | ||
| "... patient. Pharmacogenetic testing is an integral part of the personalized strategy of psychopharmacotherapy ..." | ||
| Vol 2, Issue 2 (2022) | Pharmacogenetic Testing of Cytochrome P450 System Enzymes in the Therapy of Bipolar Affective Disorder | Abstract PDF (Eng) similar documents |
| A. K. Khasanova, R. F. Nasyrova | ||
| "... to a genetically determined impairment of PDs metabolism by cytochrome P450 enzymes. Pharmacogenetic testing (PGx ..." | ||
| 1 - 7 of 7 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
